UVB Protection: Meet Penilumamide, the Skin Guardian

Ever wondered how to shield your skin from the sun's harsh UVB rays? Meet penilumamide, a new superhero in the skincare world. This innovative SIRT1 activator, penilumamide, was tested in human HaCaT cells to see if it could combat the damages caused by UVB radiation. Scientists found that penilumamide was better than resveratrol, a known natural SIRT1 activator, at boosting SIRT1 enzyme activity. In experiments, HaCaT cells were prepped with penilumamide before being exposed to UVB light. The UVB light was strong enough to hit the cells with 40 mJ/cm², but penilumamide stepped in and prevented the cells from dying off. It also cut down on the harmful reactive oxygen species (ROS) that UVB exposure creates.

Not only that, but penilumamide kept the mitochondria, the tiny powerhouses in cells, from taking a hit. It also lowered levels of pro-inflammatory cytokines, like IL-6, IL-8, and IL-10, and kept nuclear factor-kB (NF-kB) from getting too activated. All these actions show that penilumamide can shield HaCaT cells from UVB-caused inflammation. So, penilumamide stands out as a powerful defender against UVB-induced ROS generation. It might just be the key to safeguarding human keratinocytes from sun damage.

Actions